Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference42 articles.
1. Cardiovascular disease;Nabel;N. Engl. J. Med.,2003
2. Combination pharmacotherapy for cardiovascular disease;Green;Ann. Intern. Med.,2005
3. A strategy to reduce cardiovascular disease by more than 80%;Wald;BMJ,2003
4. Land mark study: “Polypill” for cardiovascular disease prevention;Venkat Narayan;Clin. Diabetes,2004
5. The polypill and cardiovascular disease, may be appropriate for secondary, but perhaps not for primary prevention;Fahey;BMJ,2005
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Era of Polypills in the Management of Cardiovascular Diseases: Are We There Yet?;Current Problems in Cardiology;2022-04
2. Emerging Multi-Drug Eutectics: Opportunities and Challenges;AAPS PharmSciTech;2021-02
3. Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy;Pharmaceutics;2021-01-18
4. Preparation and characterization of polypills containing aspirin and simvastatin using 3D printing technology for the prevention of cardiovascular diseases;Drug Development and Industrial Pharmacy;2020-09-25
5. Rationale and strategies for formulation development of oral fixed dose combination drug products;Journal of Pharmaceutical Investigation;2016-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3